2021 was a very unusual year at the Connecticut General Assembly. The Connecticut Capitol may have been closed to the public because of COVID-19 restrictions, but AARP Connecticut staff and volunteers were still vocal and active, virtually advocating on behalf of older adults and submitting nearly 50 pieces of legislative testimony. Below is a summary of the AARP Connecticut-supported bills that successfully passed both the House and Senate and are expected to be signed into law.
AARP is now accepting nominations for its 2021 Connecticut Andrus Award for Community Service, which honors an outstanding volunteer in the state who is sharing their experience, talent, and skills to enrich the lives of their community members. Do you know an extraordinary volunteer age 50 or over who should receive AARP’s most prestigious Connecticut volunteer award? The deadline is September 15, so nominate them now.
AARP Connecticut’s Disrupt Aging course covers demographic and aging trends, ageism, the importance of recognizing older adults as multidimensional individuals and examining everyone’s stake in the aging trend.
AARP Connecticut issued the following comment in response the Connecticut Public Utility Regulatory Authority (PURA) ruling on Docket 20-08-03 - Investigation into Electric Distribution Companies’ Preparation for and Response to Tropical Storm Isaias:
AARP is pleased with portions of Governor Lamont’s plan for ARPA Funds, but sees opportunities for additional investments in Home and Community-Based Services
AARP Connecticut State Director Nora Duncan provided the following statement in regards to the budget proposals of the Connecticut General Assembly’s Appropriations Committee:
AARP Connecticut issued the following comment in response to an Eversource Energy electricity rate increase request filed with the Connecticut Public Utility Regulatory Authority (PURA).
AARP Connecticut sent the below letter to Governor Ned Lamont calling for a continued focus on the need to equitably, safely and effectively distribute COVID-19 vaccines.